UBS ASSET MANAGEMENT AMERICAS LLC - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q3 2020$3,135,412,000
-93.6%
83,300
-93.1%
0.00%
-93.3%
Q2 2020$49,120,542,000
-8.0%
1,204,230
-14.6%
0.03%
-21.1%
Q1 2020$53,413,533,000
-1.9%
1,409,700
+21.7%
0.04%
+15.2%
Q4 2019$54,437,915,000
+7.9%
1,158,500
-2.0%
0.03%
-2.9%
Q3 2019$50,459,625,000
+607.3%
1,182,278
+563.2%
0.03%
+580.0%
Q2 2019$7,134,085,000
+22.3%
178,263
+27.7%
0.01%
+25.0%
Q1 2019$5,832,463,000
-6.5%
139,566
-14.5%
0.00%
-20.0%
Q4 2018$6,238,432,000
-1.3%
163,267
+3.8%
0.01%0.0%
Q3 2018$6,317,857,000
+176.0%
157,278
+177.0%
0.01%
+150.0%
Q2 2018$2,289,044,000
+12804.7%
56,786
+12407.9%
0.00%
Q1 2018$17,738,000
-37.2%
454
-43.0%
0.00%
Q4 2017$28,234,000
+7.3%
796
+22.8%
0.00%
Q3 2017$26,309,000
-5.8%
6480.0%0.00%
Q2 2017$27,942,000
-1.8%
648
-4.0%
0.00%
Q1 2017$28,458,000
+91700.0%
675
-16.9%
0.00%
Q4 2016$31,000
-85.1%
812
-79.1%
0.00%
Q2 2014$208,000
+0.5%
3,887
+0.4%
0.00%
Q1 2014$207,000
-4.2%
3,870
-4.2%
0.00%
Q4 2013$216,000
+0.9%
4,041
-5.7%
0.00%
Q2 2013$214,0004,2870.00%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2020
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 668,200$30,717,0009.01%
Camber Capital Management LP 1,200,000$55,164,0005.18%
Camber Capital Management LP 1,000,000$45,970,0004.32%
Gary Goldberg Planning Services Inc 178,496$8,205,0003.41%
Hamlin Capital Management, LLC 1,217,870$55,985,0003.36%
Winch Advisory Services, LLC 109,101$5,015,0003.22%
NORTHROAD CAPITAL MANAGEMENT LLC 151,701$6,974,0002.69%
Reynders McVeigh Capital Management, LLC 296,118$13,613,0002.59%
SALEM CAPITAL MANAGEMENT INC 120,520$5,540,0002.58%
Keystone Financial Planning, Inc. 74,338$3,417,0002.58%
View complete list of GLAXOSMITHKLINE PLC shareholders